Related Experiment Video
Updated: Jun 4, 2026

Cross-Modal Multivariate Pattern Analysis
Published on: November 9, 2011
A note on MAR, identifying restrictions, model comparison, and sensitivity analysis in pattern mixture models with
Chenguang Wang1, Michael J Daniels
1Division of Biostatistics, Center for Devices and Radiological Health, FDA, Silver Spring, Maryland 20993, USA. chenguang.wang@fda.hhs.gov
Pattern mixture models help analyze incomplete longitudinal data but face identification challenges. This study explores conditions for missing at random (MAR) identification and proposes new methods for robust analysis, especially with covariates.
Area of Science:
- Statistics
- Biostatistics
Background:
- Pattern mixture models are common for incomplete longitudinal data.
- These models often lack inherent identifiability, requiring specific restrictions.
- Existing identification strategies, particularly for missing at random (MAR) assumptions, can be problematic with multivariate normal models and covariates.
Purpose of the Study:
- To investigate the conditions under which identifying restrictions for MAR exist in pattern mixture models with multivariate normality.
- To explore strategies for identifying sensitivity parameters for sensitivity analysis or Bayesian analysis.
- To propose alternative modeling and sensitivity analysis approaches using less restrictive distributional assumptions and address issues with covariates.
Main Methods:
- Exploration of necessary conditions for MAR identifying restrictions under multivariate normality.
- Development of strategies for identifying sensitivity parameters.
- Proposal of alternative modeling strategies with less restrictive distributional assumptions.
- Utilizing the deviance information criterion (DIC) for model comparison.
- Conducting a simulation study and applying methods to a longitudinal clinical trial.
Main Results:
- Identified conditions for MAR identifying restrictions under multivariate normality.
- Demonstrated potential issues with baseline covariates and proposed a residual-based identifying restriction as a solution.
- Evaluated the performance of different modeling approaches through simulation and real-world data.
Conclusions:
- The study clarifies conditions for identifiability in pattern mixture models, particularly concerning MAR assumptions.
- Alternative methods are proposed to overcome limitations of existing approaches, especially when dealing with complex covariate structures.
- The findings offer practical solutions for analyzing incomplete longitudinal data more robustly.
More Related Videos
08:27Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
Published on: September 27, 2019
08:51Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
Published on: September 20, 2024
Related Concept Videos
Mechanistic Models: Compartment Models in Individual and Population Analysis
Clearance Models: Noncompartmental Models
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...